Medpace Holdings Inc (MEDP) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medpace Holdings Inc   (NASDAQ: MEDP)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Medpace Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medpace Holdings Inc's ROI in the second quarter of 2026?
Medpace Holdings Inc achieved a return on average invested assets (ROI) of 38.91 % in its second quarter of 2026, this is above MEDP's average return on investment of 20.86%.
Medpace Holdings Inc invested over the 12 months ending in its second quarter of 2026 $1,263 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 33 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 65 to 176.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 7.66 % 25.35 % 43.05 % 39.91 % 49.64 %
Y / Y Net Income Change TTM 17.5 % 10.57 % 49.48 % 134.34 % 373.45 %
Investment (TTM) in Millions 622 1,641 1,486 1,303 1,160
Return On Investment (TTM) 38.91 % 32.94 % 33.15 % 34.97 % 35.65 %
MEDP's Overall Ranking # 176 # 65 # 51 # 81 # 87
Seq. Investment Change TTM -9.63 % 2.7 % 9.89 % 5.56 % 5.23 %
Seq. Net Income Change TTM 6.76 % 2.06 % 4.18 % 3.52 % 0.46 %
Net Income (TTM) in Millions 492 460 451 433 418

MEDP Company Profile >> Back to MEDP Roi Comparisons >> See Annual MEDP Return On Investment



Return On Investment MEDP's Ranking
Within: No.
Industry # 1
Sector # 34
Overall # 176

Return On Investment Statistics
High Average Low
40.11 %
20.86 %
2.15 %
(Mar 31 2023)   (Dec 31 2016)







Financial Statements
Medpace Holdings Inc's II. Quarter Investments $ 622 Millions MEDP's Balance sheet
Medpace Holdings Inc's II. Quarter Income $ 121 Millions Quarterly MEDP's Income Statement
MEDP's Income by Division See MEDP's Income by Division


MEDP Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 632 996 732 549 1,103
Y / Y Investment Growth -36.59 % 36.16 % 33.27 % -50.21 % 16.01 %
Net Income in Millions 451 404 283 245 182
Y / Y Net Income Growth 11.56 % 42.99 % 15.26 % 34.93 % 25.08 %
Annual Return On Investment 71.41 % 40.59 % 38.65 % 44.69 % 16.49 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 71.41 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MEDP's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MEDP's Competitors
Subscribers only: Roi for Medpace Holdings Inc's Suppliers
Subscribers only: Return On Investment for MEDP's Customers

Other Ratios
MEDP's Roa MEDP's Inventory Turnover Ratio MEDP's Growth Rates MEDP's Dividend Statistics
MEDP's Profitability Ratios MEDP's Asset Turnover Ratio MEDP's Dividend Growth
MEDP's Roe MEDP's Valuation Ratios MEDP's Financial Strength Ratios MEDP's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Interpace Biosciences Inc   100.71 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %

Date modified: 2026-09-08T20:54:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.